Atlas Trials

A Study of INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH

Clinical trial NCT05945537 · RECRUITING

Trial details

NCT number
NCT05945537
Sponsor
Inipharm Australia Pty Ltd
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Metabolic Dysfunction-Associated Steatohepatitis
Start date
2023-09-08
Primary completion
2026-09-30
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.